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Objective: Limb loss after lower extremity surgical revascularization occurs relatively frequently in patients receiving
dialysis. The goal of the present study was to determine whether patients with milder degrees of renal insufficiency are also
at risk for this complication.
Material and methods: This cohort study was carried out at the Department of Veterans Affairs (VA). The study sample
consisted of 9932 patients undergoing an initial surgical revascularization procedure between October 1, 1995, and
September 30, 2000, recorded by the VA National Surgical Quality Improvement Program (NSQIP). We examined the
occurrence of major amputation within 1 year of lower extremity surgical revascularization by level of renal function.
Results: Eleven percent of study patients underwent major lower extremity amputation within 1 year of NSQIP-
documented lower extremity revascularization surgery: 10% (739 of 7335) of patients with normal renal function, 11%
(251 of 2210) of patients with moderately reduced renal function, 12% (24 of 205) of patients with severe renal
insufficiency, and 29% (53 of 182) of patients receiving dialysis. After adjustment for demographic characteristics and
comorbid conditions, only patients receiving dialysis were at significantly increased risk for amputation, compared with
patients with normal renal function (odds ratio, 2.46; 95% confidence interval, 1.74-3.47; P < .001). Compared with all
other veterans undergoing bypass procedures, patients receiving dialysis were more likely to have a wound infection; a
diagnostic code for lower extremity gangrene, infection, or ischemic ulceration; an elevated white blood cell count; and
preoperative sepsis at the time of initial revascularization. In addition, they were more likely to have a preoperative
hospital stay longer than 1 week, undergo concurrent minor amputation, and undergo an outflow (vs inflow) procedure.
Conclusion: Only patients receiving dialysis, and not patients with milder degrees of renal insufficiency, appear to be at
higher risk for limb loss after revascularization, compared with patients with normal renal function. Further studies are needed
to determine why patients receiving dialysis are at a singularly increased risk for limb loss after lower extremity revasculariza-
tion and whether their more frequent presentation with limb-threatening infection at the time of revascularization reflects late
presentation for surgery or a more rapid course of peripheral arterial disease in this patient group. (J Vasc Surg 2004;39:
709-16.)Numerous retrospective case series have reported rela- revascularization in patients with renal insufficiency com-
tively low limb salvage rates after lower extremity surgical
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doi:10.1016/j.jvs.2003.11.038pared with those with normal renal function.1-15 The rela-
tively frequent requirement for amputation after lower
extremity revascularization in this group16 is a well-recog-
nized phenomenon that raises important questions about
the appropriateness of revascularization over primary am-
putation.5
Many previous studies that specifically examined the
contribution of renal insufficiency to limb salvage rates
after revascularization either focused solely on patients
receiving dialysis or grouped patients receiving dialysis
with renal transplant patients and those with milder
forms of renal insufficiency.1-15 Thus it is not known
whether patients with milder forms of renal insufficiency
are also at increased risk for limb loss after lower extrem-
ity revascularization. Many of the factors that appear to
predispose patients receiving dialysis to atherosclerotic
events are also applicable in patients with milder degrees
of renal insufficiency.17 Furthermore, for a variety of
surgical procedures, including lower extremity revascu-
larization, the incidence of many postoperative compli-
cations is increased, not only for patients receiving dial-709
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insufficiency.18-22
We used prospectively collected data from the Depart-
ment of Veterans Affairs (VA) National Surgical Quality
Improvement Program (NSQIP), linked to International
Classification of Diseases, ninth revision (ICD-9)–coded
VA hospital administrative data for the same veterans, to
study the association of renal insufficiency with the inci-
dence of early major lower extremity amputation, defined
as, amputation at the level of the ankle or higher occurring
within 1 year of lower extremity bypass graft surgery. We
hypothesized that there would be a high incidence of
post-revascularization amputation in patients receiving di-
alysis, but that in addition there would be a graded increase
in risk for amputation after lower extremity revasculariza-
tion with advancing degrees of renal insufficiency. We also
hypothesized that the association of renal insufficiency with
early amputation might be explained in part by the presence
among these patients of a more distal pattern of lower
extremity disease at revascularization or by their more
frequent presentation with advanced lower extremity soft
tissue injury at revascularization.
METHODS
Databases. Index surgical revascularization proce-
dures were identified with the VA NSQIP database, an
ongoing quality management initiative for surgical care.
Since its inception on January 1, 1994, NSQIP has pro-
spectively collected data on most major surgeries occurring
at VA medical centers (VAMCs) across the United States. A
detailed account of NSQIP study design and validation
methods is provided elsewhere.23 One hundred twenty-
three VAMCs participate in NSQIP. Procedures performed
with the patient under general, spinal, or epidural anesthe-
sia are eligible for inclusion in NSQIP. Patients are enrolled
in NSQIP at surgery, at which time data on baseline clinical
and demographic characteristics are obtained from the
medical record, patient interview, or the surgeon caring for
the patient. Preoperative laboratory values are transmitted
electronically from the VAMC decentralized hospital com-
puter system (VistA) to the coordinating center at the
Denver VA Medical Center and the University of Colorado
Health Outcomes Program. Patients are then surveilled
prospectively into surgery and for 30 days after surgery by
surgical clinical nurse reviewers. Data regarding the surgery
and postsurgical complications occurring within 30 days
are ascertained by these nurse reviewers, using the medical
record, surgeon interview, and patient follow-up by letter
or telephone call. The medical record is reviewed for 100%
of patients undergoing a NSQIP-recorded procedure. Un-
like hospital discharge databases, in which data capture is
frequently incomplete and lacking in clinical detail, NSQIP
has a managerial and reporting structure designed to enable
continuous monitoring and enhancement of surgical care
in VAMCs.23 Nurse reviewers receive annual training in
NSQIP operations, and are required to take proficiency
examinations at regular intervals. These nurses are not part
of the surgery services at the local VAMC where they arebased, but operate within the structure of NSQIP. A net-
work of regional NSQIP nurse leaders and a system of
biweekly conference calls are in place to support nurse
reviewers. Finally, to maintain high-quality data collection,
NSQIP periodically conducts site visits at individual
centers.
Amputations occurring after initial revascularization
were identified with the VA administrative database24 (ie,
the Patient Treatment File Surgery and Procedure files,
Extended Care Surgery and Procedures files, and non-VA
Surgery and Procedures files) and NSQIP. Non-VA Sur-
gery and Procedure files contain information about epi-
sodes of care provided for veterans by non-VA institutions
under VA contract. Patient deaths were ascertained with
the Beneficiary Identification and Records Locator System
death records.25,26 The study was approved by the Re-
search and Development Committee of the San Francisco
VA Medical Center and by the Committee on Human
Research at the University of California, San Francisco.
Sample selection. The following database search was
designed to identify all lower extremity surgical revascular-
ization procedures recorded as principal procedures in the
NSQIP database from October 1, 1995, through Septem-
ber 30, 2000, in which the patient had not undergone a
previous major amputation or lower extremity revascular-
ization in a VAMC. The study did not include percutaneous
revascularization procedures. Initially we searched the NS-
QIP database for patients undergoing their first lower
extremity surgical revascularization between October 1,
1993, and September 30, 2000. The NSQIP search was
conducted with current procedural terminology (CPT) codes
for lower extremity surgical revascularization. We searched for
the first occurrence of at least one of the CPT codes identified,
and retained for further analysis the chronologically first
bypass procedure performed between October 1, 1995,
and September 30, 2000. Patients who underwent a NS-
QIP-recorded major lower extremity amputation, either as
a principal or nonprincipal procedure, after January 1,
1993, and before or at the same time as the index revascu-
larization procedure were excluded from the analysis.
Because not all surgical procedures recorded in the
administrative database are captured by NSQIP, we ex-
cluded patients who had undergone a previous lower ex-
tremity revascularization or major amputation in the VA by
also searching VA administrative databases for previous
revascularization or major amputation procedures, includ-
ing nonprincipal procedures, from October 1, 1993, 2
years before the beginning of the study period. ICD-9
procedure codes were used to identify these procedures.
Definition of renal function. A single preoperative
serum creatinine concentration measurement was available
for most patients in the NSQIP database. In addition, nurse
reviewers, who have access to the medical record, also
recorded whether patients experienced preoperative acute
renal failure, defined by NSQIP as rapidly rising creatinine
concentration greater than 3 mg/dL and oliguria. Glomer-
ular filtration rate (GFR) was calculated for each patient
with the abbreviated Modification of Diet in Renal Disease
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nine concentration, age, gender, and race.27
Patients were grouped according to level of renal func-
tion: normal or mildly reduced renal function (estimated
GFR, 60 mL/min/1.73 m2), moderate renal insuffi-
ciency (estimated GFR, 30-59 mL/min/1.73 m2), severe
renal insufficiency (estimated GFR, 30 mL/min/1.73
m2), and dialysis-dependent renal failure. This classification
is similar to the definition recommended by the National
Kidney Foundation Dialysis Outcome Quality Initiative
(NKF-DOQI) guidelines for chronic kidney disease28, with
one exception: to draw comparisons between patients re-
ceiving dialysis and those not receiving dialysis, the small
number of patients with estimated GFR 15 mL/min/
1.73 m2 but not receiving dialysis were included in the
group with severe renal insufficiency (estimated GFR,30
mL/min/1.73 m2) and not included with patients receiv-
ing dialysis in a “kidney failure” category, as suggested by
NKF-DOQI guidelines. We excluded from the analysis all
patients who had preoperative acute renal failure, to include
only patients likely to have chronic renal insufficiency.
Outcome variable. The outcome of interest in this
analysis was the occurrence of a major nontraumatic lower
extremity amputation during the first post-revasculariza-
tion year, defined as any amputation at the level of the ankle
or above, recorded as a principal or nonprincipal procedure
either in NSQIP or the VA administrative database.
Baseline patient demographic characteristics and
comorbid conditions. Patient demographic characteris-
tics included age, race, and sex. Age was dichotomized at
the median value of 66 years, and patient race was defined
as black versus non-black. Comorbid conditions prospec-
tively recorded by NSQIP coordinators before the proce-
dure included diabetes (categorized according to whether
the patient was receiving an oral hypoglycemic agent or
daily insulin), chronic obstructive pulmonary disease, his-
tory of congestive heart failure (CHF) during the month
before surgery, history of stroke with neurologic deficit,
current smoking (within 1 year of the procedure), and
current alcohol use.
Patient clinical status at surgery. Variables that indi-
cated the patient’s clinical findings at revascularization that
we postulated might be part of the causal pathway for
amputation after revascularization included the presence of
wound infection at surgery; postoperative diagnosis re-
corded by the surgeon of any one of the following condi-
tions: gangrene, foot cellulitis or abcess, osteomyelitis, foot
ulceration (ICD-9 codes 440.23, 440.24, 681.1, 707.1,
707.8-707.9, 785.4); white blood cell count at surgery;
preoperative sepsis; need for an emergency procedure (pro-
cedures were deemed emergencies in NSQIP if referred to
as “emergent” by either the surgeon or the anesthesiolo-
gist); pre-revascularization hospital length of stay, dichot-
omized a priori at the 75th percentile (7 days); whether the
patient underwent a concurrent minor amputation (toe or
through foot) under the same anesthetic as the revascular-
ization procedure; and type of revascularization procedure
performed. Revascularization procedures were classified asinflow procedures if they provided blood to the inguinal
vessels (common femoral, superficial femoral, or profunda
femoris arteries), and as outflow procedures if they pro-
vided blood supply to or beyond the popliteal artery. Out-
flow procedures were further classified into popliteal and
subpopliteal (to the tibial or peroneal arteries) procedures.
CPT codes were used to categorize revascularization pro-
cedures in this way.
Statistical analysis. Baseline patient characteristics
across renal insufficiency categories were compared with
the reference category of persons with normal or mildly
reduced renal function with the 2 test. We used logistic
regression analysis to measure the association of renal func-
tion with the occurrence of at least one major lower extrem-
ity amputation within 1 year of revascularization, adjusted
for patient baseline demographic characteristics and co-
morbid conditions. We also used logistic regression analysis
to measure the association of variables indicating preoper-
ative clinical presentation with dialysis status, to explore the
hypothesis that high post-revascularization amputation
rates among patients receiving dialysis might reflect more
advanced limb ischemia or limb-threatening infection at
revascularization. Each analysis was adjusted for demo-
graphic characteristics and comorbid conditions that were
associated with both renal insufficiency and the particular
covariate, to adjust for confounding. We then measured the
association of renal insufficiency with early amputation
further adjusted for covariates in the aforementioned anal-
ysis that were independently associated with dialysis status.
Patients with missing data for any one variable were ex-
cluded from multivariable analysis. We repeated our
analysis, excluding all patients who died during the study
period, to confirm that inclusion of patients who died did
not bias the results.
RESULTS
We identified 10,478 principal procedure lower ex-
tremity surgical revascularizations in NSQIP in which the
patient had not undergone a previous lower extremity
revascularization or major amputation within the VA re-
corded either in NSQIP or in the VA administrative data-
base. Of these, 3 patients were excluded because of inaccu-
rate operative or death dates and 489 patients were
excluded because they lacked data regarding preoperative
renal function, either preoperative serum creatinine con-
centration or an indication that the patient was receiving
dialysis at the time of surgery. Fifty-four of the remaining
patients had preoperative acute renal failure, defined by
NSQIP as creatinine concentration rapidly rising to greater
than 3 mg/dL and oliguria, and were excluded from the
analysis. The study sample thus consisted of 9932 patients
undergoing their first lower extremity revascularization in
the VA between October 1, 1995, and September 30,
2000.
Among study patients, 7335 patients (74%) had normal
or mildly reduced renal function (GFR 60 mL/min/
1.73 m2), 2210 patients (22%) had moderately reduced
renal function (GFR 30-59 mL/min/1.73 m2), 205 pa-
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receiving dialysis (GFR 30 mL/min/1.73 m2), and 182
patients (2%) were receiving dialysis at the time of revascu-
larization. Characteristics of the study population accord-
ing to degree of renal function are shown in Table I.
Percentage of patients with diabetes receiving daily insulin,
with CHF, and with stroke with neurologic deficit tended
to increase along with degree of renal dysfunction, whereas
percentage of patients who were alcohol users or smokers
tended to decrease with worsening renal function. Percent
of African Americans was higher in the dialysis group.
Finally, as the degree of renal insufficiency increased, there
was a progressive decrease in the percentage of inflow
procedures and an increase in the percentage of subpopli-
teal outflow procedures. The percentage of popliteal out-
flow procedures (femoropopliteal) was slightly higher for
Table II. Univariate and multivariate logistic regression an
Level of renal function Unadjusted
Normal or mildly reduced (GFR 60 mL/
min/1.73 m2)
1.00
Moderate (GFR 30-59 mL/min/1.73 m2) 1.14
Severe (GFR 30 mL/min/1.73 m2) 1.18
Dialysis-dependent 3.67
GFR, Glomerular filtration rate; OR, odds ratio; CI, 95% confidence interv
*Multivariate analysis is adjusted for all baseline demographic data and com
with outcome (ie, age, race, diabetes, CHF, stroke, alcohol use).
†P  .001.
Table I. Baseline demographic data, comorbid conditions
Variable (percent data missing)
Norma
(n  73
Demographic data
Age 66 y (%) 41
Male gender (%) 99
Black race (4%) (%) 17
Comorbidity
Diabetes, with oral hypoglycemic agent (%) 16
Diabetes, with daily insulin (%) 15
CHF (%) 3
Stroke with neurologic deficit (%) 9
COPD (%) 19
Alcohol user (1%) (%) 16
Smoker (%) 63
Type of procedure
Inflow (%) 50
Outflow, popliteal artery (%) 29
Outflow, subpopliteal (%) 22
CHF, Congestive heart failure; COPD, chronic obstructive pulmonary dise
P values pertain to chi2 tests comparing each renal insufficiency category with
rate. Percentages for type of revascularization procedure may not total 100
*P  .001.
†P  .05.
‡P  .01.those with moderate renal insufficiency but similar for all
other groups.
The incidence of major lower extremity amputation,
death, and either of these outcomes during the year after
revascularization for each renal function group is shown in
the Fig. Amputation rate was similar across all renal insuf-
ficiency groups except for patients receiving dialysis, in
whom the amputation rate was almost threefold that
among other groups. Death rates increased with worsening
renal function. Consequently, more than half of all patients
receiving dialysis either died or underwent major lower
extremity amputation, or both, during the year after lower
extremity revascularization. Univariate and multivariate lo-
gistic regression analyses of level of renal function with the
outcome of amputation within 1 year of lower extremity
revascularization are shown in Table II. In unadjusted
s of amputation within 1 year of revascularization
Amputation
CI Adjusted* OR CI
1.00
0.98, 1.33 0.94 0.80, 1.10
0.77, 1.82 0.84 0.54, 1.32
2.64, 5.09† 2.46 1.74, 3.47†
onditions that differed across renal function categories and were associated
type of revascularization procedure
Level of renal disease
Moderate
(n  2210)
Severe
(n  205)
Dialysis
(n  182)
68* 69* 49†
98* 97‡ 98
12* 11† 43*
17 16 15
25* 37* 44*
7* 10* 10*
13* 14† 14†
22† 19 16
8* 9† 2*
45* 41* 25*
41* 36* 17*
31† 29 32
29* 35* 52*
ferent category of those with normal or mildly reduced glomerular filtration
ause of rounding.alysi
OR
al.
orbid c, and
l
34)
ase.
the re
%, bec
JOURNAL OF VASCULAR SURGERY
Volume 39, Number 4 O’Hare et al 713analysis and after adjustment for baseline demographic
characteristics and comorbid conditions that were associ-
ated with the outcome in univariate analysis (age, race,
diabetes, history of CHF, history of stroke, and alcohol
use), only dialysis-dependent renal failure, and not milder
levels of renal insufficiency, was significantly associated with
amputation after lower extremity revascularization.
To test the hypothesis that high post-revascularization
amputation rates among patients receiving dialysis might
reflect more advanced limb ischemia or limb-threatening
infection at revascularization, we examined the association
of dialysis status with variables indicating patient clinical
findings at surgery (Table III). Each analysis is adjusted for
all other demographic characteristics and comorbid condi-
tions that were also associated with the specific outcome
examined. Patients receiving dialysis were more likely to
have a wound infection; a postoperative ICD-9 diagnosis of
gangrene, ulceration, or lower extremity infection; an ele-
Table III. Prevalence and association of clinical findings a
Variable (% data missing)
Prevalence among
patients receiving
dialysis
Wound infection (%) 65
Postoperative diagnostic code for lower
extremity infection or gangrene† (%)
29
WBC  12,000 (1%) (%) 25
Preoperative sepsis (%) 4
Emergency procedure (%) 7
Preoperative hospital stay 7 d (1%) (%) 37
Inflow procedures (%) 17
Outflow procedures, popliteal (%) 32
Outflow procedures, subpopliteal (%) 52
Concurrent minor amputation (%) 10
WBC, White blood cell count; ICD-9, International Classification of Dise
pulmonary disease; OR, odds ratio; CI, 95% confidence interval.
*Adjusted for age, race, diabetes, CHF, COPD, and stroke.
†ICD-9 codes 440.23, 440.24, 681.1, 707.1, 707.8-707.9, or 785.4.
‡Adjusted for age, diabetes, race, and COPD.
§Adjusted for diabetes, CHF, COPD, and smoking.
Adjusted for sex and diabetes.
¶Adjusted for diabetes, CHF, COPD, and smoking.
#Adjusted for age, race, diabetes, CHF, stroke, and alcohol use.
**Adjusted for age, race, diabetes, CHF, smoking, and alcohol use.
††Adjusted for age, race, diabetes, COPD, stroke, and alcohol use.
Table IV. Association of dialysis status with amputation af
Model
Unadjusted
Adjusted for demographic data and comorbidities*
Further adjusted for preoperative condition†
*Adjusted for all demographic data and comorbid conditions associated with
alcohol use).
†Additionally adjusted for all preoperative and operative data associated with
code) for gangrene or lower extremity infection, preoperative white blood ce
and type of procedure (ie, inflow procedure vs outflow procedure; popliteavated white blood cell count; preoperative sepsis; require-
ment for a more distal procedure; requirement for concur-
rent minor amputation; and pre-revascularization hospital
stay of more than 7 days, even after adjustment for con-
founders. The association of dialysis status with amputation
after revascularization was substantially attenuated by in-
clusion of these variables (Table IV). The results of these
analyses did not change substantially when we excluded
patients who died.
DISCUSSION
There is an extremely high risk for amputation within
the first year after lower extremity revascularization in
patients receiving dialysis (29% vs 10% in patients with
normal or mildly reduced renal function), which is not
shared by patients with milder forms of renal insufficiency.
Overall, fewer than 50% of patients receiving dialysis who
underwent lower extremity revascularization survived
scularization, with dialysis status
Prevalence among
tients not receiving
dialysis Adjusted OR CI P
28 3.22 2.30, 4.50* .001
13 2.01 1.43, 2.83‡ .001
10 2.97 2.09, 4.21§ .001
1 3.89 1.72, 8.80 .001
5 1.62 0.91, 2.90¶
22 1.50 1.09, 2.06# .05
47 0.33 0.22, 0.50** .001
29 1.11 0.80, 1.53**
24 2.13 1.55, 2.93** .001
4 1.71 1.02, 2.87† .05
ninth revision; CHF, congestive heart failure; COPD, chronic obstructive
evascularization
Odds
ratio
95%
confidence
interval P
3.54 2.55, 4.90 .001
2.51 1.79, 3.53 .001
1.67 1.17, 2.37 .005
tation within 1 year of revascularization (ie, age, race, diabetes, CHF, stroke,
ialysis status and amputation (ie, wound infection, postoperative diagnostic
t, preoperative sepsis, hospital stay7 days, concurrent minor amputation,
tflow procedure, subpoplitcal).t reva
pa
asses,ter r
ampu
both d
ll coun
l vs ou
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amputation. Since our sample included only the select
group of patients who had not previously undergone am-
putation or revascularization, overall rates of limb loss after
revascularization, including repeat and second procedures,
are probably even higher than reported here.
The lack of a graded increase in risk for amputation
after lower extremity revascularization with worsening re-
nal function is somewhat surprising, because patients with
mild to moderate renal insufficiency are at increased risk for
adverse outcomes such as death and cardiovascular compli-
cations after both lower extremity revascularization29 and
other surgeries.18-22 Furthermore, many of the same pro-
cesses that predispose to atherosclerosis in patients receiv-
ing dialysis are also ongoing in patients with milder forms of
renal insufficiency.17 The singularly high incidence of limb
loss after revascularization in patients receiving dialysis may
be partially explained by the higher prevalence of insulin-
requiring diabetes and requirement for more distal proce-
dures in this group. However, patients receiving dialysis
were still at increased risk for limb loss after adjustment for
diabetes and type of procedure, in addition to other demo-
graphic and clinical characteristics. Alternative explanations
include the presence of more severe underlying comorbid
conditions, in particular, diabetes; or the presence among
dialysis patients of a form of atherosclerosis that is more
likely to progress or for which revascularization is less
appropriate (eg, more distal disease, higher prevalence of
vascular calcification), impaired lower extremity wound
healing associated with renal insufficiency,30 or greater
tendency for advanced lower extremity soft tissue injury at
the time of lower extremity revascularization.
Our findings raise the question of whether worse lower
extremity outcomes are seen in patients receiving dialysis as
the result of the presence of more advanced soft tissue
infection. This may reflect the fact that these procedures are
being performed relatively late in the course of lower ex-
tremity disease, when there is already extensive soft tissue
injury. In a case-control study of lower extremity revascu-
larization, Reddan et al31 reported that patients receiving
Percentage of patients in each group with renal insufficiency with
amputation (light gray bars), death (dark gray bars), or either
outcome (black bars) during the year after lower extremity revas-
cularization.dialysis were more likely than control subjects matched for
age, sex, and diabetes to have gangrene or ulceration, as
compared with rest pain and claudication. In the present
study, even after adjustment for confounding factors, pa-
tients receiving dialysis were more likely to have wound
infection, elevated white blood cell count, and preoperative
sepsis; a diagnosis of gangrene or lower extremity ulcer or
infection by ICD-9 code; preoperative hospital stay lasting
more than 1 week; and to require concurrent minor ampu-
tation. These findings probably indicate a higher prevalence
of limb-threatening infection in the dialysis group com-
pared with the non-dialysis group undergoing revascular-
ization.
There are several possible explanations for the more
frequent finding of advanced lower extremity soft tissue
injury in patients receiving dialysis. It is possible that this
could reflect a relative reluctance on the part of clinicians
caring for these patients to subject them to the risks asso-
ciated with lower extremity revascularization surgery. This
may be particularly true at earlier stages of disease, in which
the perceived risk-benefit ratio of revascularization may be
less favorable than later in the disease course in this group at
high surgical risk. Alternatively, the more frequent finding
of advanced soft tissue infection in patients receiving dial-
ysis may reflect more rapid disease progression in this
group, perhaps outstripping the normal pace of disease
recognition and surgical referral. Further studies are
needed to determine which, if any, of these processes might
explain the higher prevalence of limb-threatening infection
in this group at revascularization.
After adjustment for type of revascularization proce-
dure and factors indicative of degree of soft tissue injury,
such as wound infection, diagnostic code for gangrene or
lower extremity ulceration or infection, white blood cell
count, or sepsis, the association of dialysis status with
amputation after revascularization was considerably atten-
uated. This suggests that poor outcomes after revascular-
ization in this group may in part be accounted for by the
nature of clinical findings at revascularization. Worse out-
comes in patients receiving dialysis, even after adjustment
for these covariates, may reflect clinical details not mea-
sured by NSQIP, such as severity of soft tissue damage,
details of vascular anatomy, presence of vascular calcifica-
tion, or impaired wound healing.
A limitation of the study is that it may not be possible to
generalize our results to non-veteran populations and to
women in particular. However, the large, multicenter study
design and prospective data collection by NSQIP offer
advantages over previous studies based on single-institu-
tion experience. A second limitation is that outcomes oc-
curring outside the VA were not captured by the present
analysis. This may have resulted in inclusion of secondary
revascularization procedures in the study sample and un-
derestimation of post-revascularization amputation rates.
However, we do not think this is a major concern, because
post-revascularization amputation rates reported here in
patients receiving dialysis are consistent with those reported
elsewhere. More concerning would be differential loss to
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we would anticipate that loss to follow-up would be more
common among patients receiving dialysis, because they
have higher rates of dual Medicare-VA use compared with
patients not receiving dialysis (D.M. Hynes, K. Stroupe,
and P. Colin; personal communication, May 2002). Thus
differential loss to follow-up would likely bias our results
toward, rather than away from, the null hypothesis; that is,
the incidence of amputation after revascularization re-
ported here for patients receiving dialysis is more likely an
underestimate than that for other groups. Finally, analysis
of indication for surgery was limited to ICD-9 diagnostic
code information rather than more detailed chart data. This
may have led to misclassification of surgical indication,
owing to the nonspecific nature of ICD-9 coding. How-
ever, inclusion in the analysis of other variables that indicate
presence of infection or tissue damage, such as preoperative
wound infection and preoperative white blood cell count,
probably overcomes this limitation.
In conclusion, unlike patients with milder degrees of
renal insufficiency, patients receiving dialysis have a high
incidence of amputation within 1 year of lower extremity
revascularization that is not explained by a higher preva-
lence of demographic characteristics and comorbid condi-
tions associated with the complication. This finding is
particularly disturbing given the high post-revasculariza-
tion mortality in this group. Poor outcomes after lower
extremity revascularization in patients receiving dialysis
may be explained in part, but not completely, by the more
frequent clinical finding of limb-threatening infection.
Further studies are needed to determine why patients
receiving dialysis are at singularly increased risk for limb loss
after lower extremity revascularization and why they are
more likely to have limb-threatening soft tissue damage at
revascularization. Specifically, such studies should attempt
to determine whether this clinical finding reflects a different
or more aggressive disease course versus differences in
clinical decision-making, such as later referral for surgery.
Such information would be helpful in identifying target
areas for interventions to improve outcomes in patients
with limb ischemia who are receiving dialysis. In addition,
decision making in this area should clearly take into account
quality of life, because these patients experience both high
amputation rates and high mortality after lower extremity
revascularization.
We thank Bharat Thakkar for performing extensive
searches of both NSQIP and the VA administrative data-
base required for this project; and Dr Charles McCulloch,
in the Department of Biostatistics and Epidemiology, Uni-
versity of California at San Francisco, for reviewing the
statistical analysis portion of this manuscript.
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